Amplia Therapeutics Limited
INNMF · OTC
9/30/2025 | 3/31/2025 | 9/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Market Cap | $43 | $28 | $33 | $15 |
| - Cash | $19 | $11 | $5 | $3 |
| + Debt | $0 | $0 | $0 | $2 |
| Enterprise Value | $24 | $17 | $29 | $13 |
| Revenue | $0 | $2 | $1 | $2 |
| % Growth | -100% | 68.9% | -29.8% | – |
| Gross Profit | -$0 | $2 | $1 | $2 |
| % Margin | – | 94.1% | 95% | 83.5% |
| EBITDA | -$4 | -$4 | -$3 | -$3 |
| % Margin | – | -167.5% | -199% | -171.7% |
| Net Income | -$3 | -$4 | -$3 | -$3 |
| % Margin | – | -158.1% | -200% | -168.3% |
| EPS Diluted | -0.007 | -0.01 | -0.011 | -0.017 |
| % Growth | 37.5% | 6.3% | 36.2% | – |
| Operating Cash Flow | -$5 | -$6 | -$1 | -$2 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$5 | -$6 | -$1 | -$2 |